Please assess the completion status of the following clinical trial:

Trial Title: Regenexx™ PL-Disc Versus Steroid Epidurals for Lumbar Radiculopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pain, spasm, or functional disability in the low back and diagnosed as radiculopathy having failed conservative treatment (e.g. NSAIDs, physician initiated physical therapy) for at least 3 months and not longer than 2 years~* Significant functional disability related to pain, lack of strength, or other back or leg symptoms~* Physical examination consistent with lumbar radiculopathy~* Lumbar disc bulge, herniation, and/or Kader grade 2 or greater multifidus atrophy evident on MRI and consistent with physical exam findings~* Is independent, ambulatory, and can comply with all post-operative evaluations and visits~Exclusion Criteria:~* Symptomatic central or foraminal stenosis~* Previous low back surgery~* Prior epidural steroid injection or other low back injection therapy within the past year~* \>50% loss of disc height at the symptomatic level~* Spondylolisthesis~* Inflammatory or auto-immune based pathology (e.g., rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, polymyalgia, polymyositis, gout pseudogout)~* Quinolone or Statin induced myopathy/tendinopathy~* Severe neurogenic inflammation of the cutaneous nerves~* Condition represents a worker's compensation case~* Currently involved in a health-related litigation procedure~* Is pregnant~* Bleeding disorders~* Currently taking anticoagulant or immunosuppressive medication~* Allergy or intolerance to study medication~* Use of chronic opioid,~* Documented history of drug abuse within six months of treatment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Regenexx PL-Disc (Type: ACTIVE_COMPARATOR): Injection of Regenexx PL-Disc into the epidural space once a week for two weeks.
- Steroid Epidural (Type: ACTIVE_COMPARATOR): Injection of steroid into the epidural space once a week for two weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).